| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.943435 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20241106100304 |
|---|
| 006 | m o d f |
|---|
| 007 | cr mn||||||||| |
|---|
| 008 | 240919e202409 onc o f000 0 eng d |
|---|
| 020 | |a9780660737287 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH14-641/2024E-PDF |
|---|
| 245 | 00|aAudit of drug shortage reporting, monitoring, and compliance activities / |cOffice of Audit and Evaluation. |
|---|
| 264 | 1|aOttawa, ON : |bHealth Canada, |cSeptember 2024. |
|---|
| 264 | 4|c©2024 |
|---|
| 300 | |a1 online resource (15 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Audit des activités de signalement, de conformité et de surveillance des pénuries de médicaments. |
|---|
| 500 | |aCover title. |
|---|
| 500 | |a"May 2024." |
|---|
| 610 | 10|aCanada. |bHealth Canada|xAuditing. |
|---|
| 650 | 0|aDrug accessibility|zCanada|xAuditing. |
|---|
| 650 | 0|aDrugs|xSupply and demand|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada. |bOffice of Audit and Evaluation, |eissuing body. |
|---|
| 775 | 08|tAudit des activités de signalement, de conformité et de surveillance des pénuries de médicaments / |w(CaOODSP)9.943436 |
|---|
| 856 | 40|qPDF|s293 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H14-641-2024-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/corporate/transparency/corporate-management-reporting/internal-audits/drug-shortage-reporting-monitoring-compliance-activities.html |
|---|
| 986 | |a240551 |
|---|